Cite
HARVARD Citation
Kurmasheva, R. et al. (2017). Initial testing of VS‐4718, a novel inhibitor of focal adhesion kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program. Pediatric blood & cancer. 64 (4), p. n/a. [Online].